Leveraging its industrial-scale Flame Spray Pyrolysis (FSP) capabilities, DELVEC successfully produced a high-performance magnetic hyperthermia material tailored for advanced biomedical applications. This material was evaluated by Professor A. Teleki’s research group at Uppsala University, Sweden, confirming its potential for precision-targeted oncological therapies.
The results of the study have been published in ACS Nano.
Read the full publication here.
